Editor-in-Chief’s Commentary: Collaborative Models for Drug Development, Evaluation, and Clinical Use Stephen P. Spielberg Commentary 30 December 2013 Pages: 630 - 631
Coalition Against Major Diseases: Precompetitive Collaborations and Regulatory Paths to Accelerating Drug Development for Neurodegenerative Diseases Diane StephensonEnrique AvilesMaria Isaac Therapeutic and Regulatory Innovation 30 December 2013 Pages: 632 - 638
The Multiple Sclerosis Outcome Assessments Consortium: Bringing the Community Together to Shape the Future of Multiple Sclerosis Drug Development Janet WoodcockAnne M. Rowzee Therapeutic and Regulatory Innovation 30 December 2013 Pages: 639 - 640
Rheumatoid Arthritis Disease Progression Modeling Russell ReeveLei PangWei Xiao Therapeutic and Regulatory Innovation 30 December 2013 Pages: 641 - 650
New Governance Mechanisms to Optimize Protocol Design Kenneth A. GetzJennifer KimKenneth I. Kaitin Therapeutic and Regulatory Innovation 30 December 2013 Pages: 651 - 655
An Exploratory Study on the Policies of Health Care Institutions in the New England Region of the United States Regarding Third-Party Access to Medical Records of Research Participants: Potential Effects on the Legal and Ethical Conduct of Clinical Trials Mark Arquiza Therapeutic and Regulatory Innovation 30 December 2013 Pages: 656 - 664
Globalizing Medical Information: The Executive Nurse as a Primary Director Timothy Fish International Perspectives 30 December 2013 Pages: 665 - 669
Statistics, Quality Review Issues, and Beyond for Generic Drug Applications in Taiwan Lin-Chau ChangChurn-Shiouh Gau International Perspectives 30 December 2013 Pages: 670 - 677
Characterizing Good Review Practices: A Survey Report Among Agencies of APEC Member Economies Li-Ling LiuNeil McAuslaneJaw-Jou Kang International Perspectives 30 December 2013 Pages: 678 - 683
Legal Requirements, Definitions, and Standards for Non-interventional Drug Studies: A Global Picture of Variability—Results and Conclusions From a Single-Institution Survey Markus HartmannPatricia Schaffner International Perspectives 30 December 2013 Pages: 684 - 691
Approvals of Pharmaceutical Drugs in China in the Post—Drug Registration Regulation II Era Tiantian ZhangJianhong TaoChuanbin Wu International Perspectives 30 December 2013 Pages: 692 - 698
Investigation Into the Antinfluenza Agent Oseltamivir Distributed via the Internet in Japan Natsumi TakahashiHirohito TsuboiKazuko Kimura International Perspectives 30 December 2013 Pages: 699 - 705
Lipodystrophy Is Common Among Ethiopian Patients on Highly Active Antiretroviral Therapy but Is Not Associated With Quality of Life or Medication Adherence Nasir Tajure WabeNezif Hussien DekamaDesta Hiko Gemeda International Perspectives 30 December 2013 Pages: 706 - 714
Overview of the Regulation of Medical Devices and Drugs in the European Union and the United States Fiona MastersonKathryn Cormican International Perspectives 30 December 2013 Pages: 715 - 722
DIA/NORD 2013 US Conference on Rare Diseases and Orphan Products: Poster Abstracts Abstracts 30 December 2013 Pages: 723 - 740
Local Evaluation and Blinded Central Review Comparison: A Victim of Meta-Analysis Shortcomings David RaunigGregory GoldmacherJames Conklin Letter to the Editor Open access 30 December 2013 Pages: NP1 - NP2
